Background: Acute kidney injury (AKI) is a common morbidity in neonatal intensive care units and associated with poor outcome. This study aimed to determine the prevalence of AKI and provide a demographic data and risk factors associated with the mortality and morbidity.
| INTRODUC TI ON
Using advanced technical and pharmacological interventions in recent years, effective treatment of many life-threatening issues in neonatal period became possible and survival rate of very low birth weight (VLBW) and extremely low birth weight babies (ELBW) has been increased. 1, 2 Nevertheless, morbidities in those babies have not been changed significantly. 2, 3 Acute renal damage (AKI) results in decreased renal function, accumulation of nitrogenous waste products, loss of fluid balance and loss of electrolyte, and acid-base homeostasis. The incidence of AKI in neonates who were admitted to the neonatal intensive care units (NICU) ranges from 3.4%-71%. This wide range is partly due to the lack of a universally accepted definition of AKI in premature babies. [4] [5] [6] [7] [8] [9] [10] [11] Development of kidneys is a dynamic event that lasts up to the 36th week. 12 Because the susceptibility of immature kidney to certain conditions such as hypotension, symptomatic patent ductus arteriosus (PDA), and sepsis as well as to some agents which were used in the treatment such as nonsteroidal anti-inflammatory drugs (NSAIDs) and aminoglycosides, can cause to or increase risk for AKI in premature babies. All these factors, alone or in combination, can lead to AKI and can affect the final number, size, morphology, and maturation of glomerules. 13, 14 It is known that being a premature is only an independent risk factor for AKI due to an incomplete nephrogenesis and low number of nephrons. [5] [6] [7] It has been also suggested that preterm babies with reduced nephron numbers are at increased risk for development of chronic kidney disease later in life. 13, 15 So, it is obvious that neonatal AKI is common and is associated with poor outcomes.
Although the risk of developing AKI in ELBW babies is higher than the other babies, this situation is not studied well. Therefore, in this study, we aimed to determine the prenatal and postnatal risk factors associated with AKI in ELBW babies. We also aimed to determine the mortality rate and the presence of various risk factors in nonsurvivor group of AKI.
| ME THODS
For this cohort study, 114 premature babies whose gestational ages between 28 and 34 weeks, who were admitted to the NICU between November 2012 and April 2013, were included. Enrolled premature babies were prospectively followed for AKI development during the first 7 postnatal days by measuring serum creatinine (SCr) at least once every other day. We excluded premature babies in whom SCr levels were not determined, babies with known renal or other congenital anomalies, chromosomal abnormalities or those who died in the first 72 hours after birth, and those with a maternal history of renal failure. The final study group composed of a total of 105 critically ill preterm babies.
Flowchart regarding the selection process was shown on Figure 1 .
They were stratified into two groups according to AKI status during the hospitalization. Of the 105 preterm babies, 21 preterm babies fulfilled the criteria for AKI during the first 7 days of life.
Clinical and laboratory characteristics of the AKI group were compared to non-AKI group.
Demographic and perinatal characteristics including gestational age (GA), gender, birth weight (BW), small for gestational age (SGA) status, mode of delivery, intubation at birth, resuscitation at birth, Apgar scores at 1st and 5th minutes, systolic and diastolic blood pressure (mm Hg) were recorded. Additional parameters such as result of blood gases at the admission, use of mechanical ventilation and/or continuous positive airway pressure (CPAP) for respiratory distress, use of postnatal steroids and surfactant, insertion of any central line, and presence of oliguria (urine output <0.5 mL/ kg per hour for more than 8 hours after birth) were also recorded. Cobas 8000 (Roche) auto-analyzer, and levels were expressed as milligrams per deciliter.
| Definition of variables
Gestational age of the babies was determined by early fetal ultrasound and new Ballard score after birth. Prematurity was defined as gestational age at birth less than 37 weeks. Premature rupture of membranes was defined as membrane rupture before the onset of labor. Asphyxia was diagnosed when patients met the following criteria: (i) metabolic or severe, combined acidemia (pH less than 7.0) in umbilical artery or first blood gas sample; (ii) Apgar score 3 or less at 5th minute of life; (iii) neonatal neurological manifestations (seizures, coma, or hypotonia); (iv) multisystemic organ dysfunction, that is cardiovascular, gastrointestinal, hematological, pulmonary, or renal systems). 16 Asphyxia was staged according to Sarnat and Sarnat Scoring System. 17 Respiratory distress syndrome was defined on the basis of clinical, laboratory, and radiological findings.
Sepsis was defined as a positive blood culture or urine culture along 
| Management
The babies who have developed AKI were treated according to the standard protocol: insuring adequate hydration [insensible loss were signed by the parents of all patients, before participating to the study.
| Statistical analysis
Statistical data were analyzed using the Statistical Package for 
| RE SULTS
The study group consisted of 105 preterm babies, 48 boys (45.7%), 57 girls (54.3%). Of the 105 preterm babies, 21 preterm babies fulfilled the criteria for AKI during the first 7 days of life (20%).
According to neonatal AKI KDIGO classification criteria; 9 patients suspected or culture-proven sepsis, and NEC in AKI group were also significantly higher than control group (P = .0002, P = .001, P = .002, P = .012, P = .001, P = .001, P = .003, P = .028, respectively). In addition, premature babies who required intubation (P = .001) and resuscitation (P = .007) at birth and placed on mechanical ventilation (P = .004) thereafter were prone to AKI development significantly higher than the others. There was a significant difference in cefotaxime, metronidazole, meropenem and teicoplanin, and vancomycin treatment between babies with and without AKI (P = .001, P = .001, P = .008, and P = .006, respectively). The overall mortality rates in babies with AKI were significantly higher than the control group during their hospitalization (61.9 vs 3.6%) (P = .0001). Risk factors in AKI and non-AKI babies were summarized in Table 1 .
Although the mean age of the mothers in AKI group was lower in control group (28.3 ± 5.4 vs 30.1 ± 5.1 years), there was no significant difference between groups (P < .05). In addition, other maternal parameters including gravidity, fever, history of any infection, antenatal steroid use, history of preeclampsia/eclampsia, maternal urinary tract infection (UTI), diabetes, early rupture of membrane (PROM), its duration (hour), placenta previa, abruption placenta, clinical chorioamnionitis, and antenatal drugs use were not statistically significant between AKI and control groups (P > .05, for each). Maternal risk factors in AKI and non-AKI babies were given in Table 2 .
All factors associated with the preterm babies with AKI and without AKI were assessed by univariate logistic regression analysis (Table 3 ). Significant variables were identified by univariate analysis ( 
TA B L E 1 (Continued)
pressures, and inotropic supports were independent risk factors for the development of AKI in preterm babies (Table 4) .
Mean BUN, SCr, serum uric acid, and eGFR values in AKI group were significantly higher than control group both on the 3rd and 7th
postnatal days of life (P = .0001, for each). No significant difference was detected in serum glucose and serum electrolyte levels between groups in the preterm babies with and without AKI on the 1st, 3rd, and 7th postnatal days of life (P > .05, for each). Only serum calcium levels in preterm babies with AKI on the postnatal day 3 were significantly lower than preterm babies without AKI (P = .003). Laboratory parameters of the preterm babies with and without AKI on postnatal days were given in Table 5 .
Thirteen of 21 infants (61.9%) with AKI died in the first 7 days of life; 7 patients (38.1%) survived. The causes of death in AKI patients were multifactorial. While 4 patients died due to major CHD; 3 patients died because of only symptomatic large PDA. The remaining 6 patients died due to various combined causes such as severe RDS, sepsis, perinatal asphyxia, or intracranial hemorrhage etc. 2 patients underwent peritoneal dialysis treatment. There was a significant relationship between KDIGO staging and mortality rate in AKI patients (P = .005). In addition, there was a significant association between mortality rate in preterm babies with AKI and oliguria, resuscitation at birth, diastolic hypotension, PDA treated with ibuprofen, inotropic support (dopamine and/or dobutamine), and furosemide treatment (P = .046, P = .048, P = .032, P = .005, P = .001 and P = .005, respectively). However, the distribution of preeclampsia/ eclampsia was significantly higher in survivor group when compared with nonsurvivors, and there was inverse association between mortality rate in preterm babies with AKI and preeclampsia/eclampsia (P = .012). Although the proportion of babies with low birth weight (LBW), VLBW, and ELBW were higher in nonsurvivors than in survivors, these findings were not statistically significant (P > .05, for each). Other parameters were not statistically significant between AKI group and control group (P > .05, for each). Risk factors for mortality of patients with AKI were given in Table 6 .
| D ISCUSS I ON
Acute kidney injury is frequent in very preterm babies and is associated with increased risk of morbidity and mortality, after adjustment for confounders, although outcomes in very preterm babies have improved over the past few decades. [7] [8] [9] [10] [11] To adjust for likely mixers, we developed a binary logistic regression model to study potential risk factors associated with AKI in premature babies. The results of our study revealed that AKI was common in LBW babies and that lower gestational ages, lower Apgar scores at 5 minutes, lower systolic blood pressures upon admission NICU, and inotropic supports (dopamine and/or dobutamine treatment due to hemodynamic instability or hypotension) were independent risk factors of AKI in LBW babies. We have also shown that LBW babies with AKI have a high mortality (61.9%) and oliguria, preeclampsia/eclampsia, lower diastolic blood pressures, PDA, inotropic supports, and furosemide treatment were associated with the mortality of these babies (P < .05, for each). Maternal UTI (n, %)
Placenta previa (n, %) 0 (0) 3 (3.6) 1.000
Abruption placenta (n, %) 2 (9.5) 0 (0) .380
Clinical chorioamnionitis (n, %) problematic owing to the call for cardiovascular support, hypotension, and hypoxia. [7] [8] [9] [10] [11] Moreover, to be only prematurity is an independent risk factor for AKI because of an insufficient nephrogenesis and low nephron count. 6, 7 Much of the studies performed on risk factors that cause AKI is followed by univariate analysis. There are few studies that have performed multivariate analysis to determine the risk factors for AKI, independent of potential confounders, and these studies revealed that lower BW, lower GA, lower Apgar scores at 1 and 5 minutes, and inotropic supports were independent risk factors for AKI in premature babies, similar to our results. AKI, acute kidney injury; M, male; F, female; SGA, small for gestational age; RDS, respiratory distress syndrome; CHD, congenital heart disease; PDA, patent ductus arteriosus; IVH, intraventricular hemorrhage; MAS, meconium aspiration syndrome; CPAP, continuous positive airway pressure. Bold indicates statistically significant value (P < .05).
TA B L E 3 (Continued)
TA B L E 4 Predictive factors in preterm babies with acute kidney injury according to multivariate binary logistic regression analysis Bold indicates statistically significant value (P < .05).
It has been noted that the incidence of AKI varies between 3.4% and 71% in critical neonates admitted to the NICU. [4] [5] [6] [7] [8] [9] [10] [11] In our study, the incidence of AKI in premature babies was 20%, which was consistent with the previous studies.
Although oliguria is another clinical finding associated with AKI, preterm babies with AKI are often nonoliguric. Nonoliguric patients have a better prognosis than oliguric patients because of less renal damage and better fluid and electrolyte homeostasis. 34 In our study, 28.6% of our patients had AKI associated with oliguria, and a big proportion had a nonoliguric AKI (71.4%), which was consistent with the literature.
The mortality of nonoliguric AKI patients ranges from 4.5%-40%, compared to 25%-78% for patients with oligo-anuric AKI. 4, 35, 36 In our study, the mortality rate in the group of preterm babies with oliguric AKI was high (46.2%) ( Table 5) 4,35,36 and we detected that AKI was associated with increased risk of mortality similar to other studies.
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Patent ductus arteriosus is prevalent in preterm babies, and a clinically apparent PDA is associated with increased risk of morbidity and mortality. Large, right to left shunt and aortic flow associated with the PDA may cause undesirable cardiac output volume and may lead to inadequate renal perfusion. 6, 39 It has also been shown in the association between nephrotoxic drug use such as NSAIDs, especially ibuprofen, and development of AKI in postnatal period in premature babies. 6, 40 In our study, the univariate analysis found that CHD except for PDA or only symptomatic PDA treated with ibuprofen was associated with the babies with AKI, which is consistent with the previous report, but multivariate analysis did not support this finding. However, we found that PDA treated with ibuprofen is a risk factor for mortality in preterm babies with AKI. This may be thought to be associated with nephrotoxicity of ibuprofen and a lethal consequence of severe AKI, or it may depend on the large PDA itself. Some studies have shown that in babies born from preeclamptic mothers has a significantly lower frequency of AKI than in babies born to mothers without preeclampsia. 8, 23 However, in a previous study, we found that preeclamptic mothers and/or pregnancyinduced hypertension were associated with AKI in preterm babies. 37 In our study, we found that preeclampsia and/or pregnancy-induced hypertension were not associated with AKI in preterm babies, consistent with the previous studies, 8, 23 but there was an inverse relationship between AKI and preeclampsia/eclampsia and mortality rate in preterm babies.
Approximately half of AKI in premature babies is associated with exposure to various medications after birth. 41 It has been indicated that babies with AKI have been exposed to antibiotics, NSAIDs, and diuretics for a long time. 6 The association between the uses of many drugs, for example, the use of inotropic support (dopamine and/or dobutamine), 23, 33 NSAIDs (ibuprofen), and various antibiotics, 6, 23, 26, 32, 33, 37, 42 and the development of AKI has been shown in neonates. In our study, the univariate analysis found that the use of many drugs was associated with the babies with AKI, which is consistent with the previous report, 6, 23, 26, 32, 33, 37, 42 but multivariate analysis did not support this finding.
Except in the case of several congenital or primary renal disorders, most AKI in neonates is reversible and transient with the correction of the underlying cause. [4] [5] [6] [7] [8] [9] [10] [11] A high mortality rate has been reported in neonate with AKI (range 25%-80%), which is consistent with our findings (our mortality rate was 61.9% in patients with AKI). [4] [5] [6] [7] [8] [9] [10] [11] There are some limitations in this work. The first one is a retrospective review that does not contain all the necessary information and is based on a file review. Second, as families cannot be followed for a long time, survivors' long-term outcomes and late-developed AKI could not be assessed. Third, we measured SCr levels at 48-72-hour intervals, which may be related to the high prevalence of AKI in neonates. Fourth, single center data reduce generalizability.
| CON CLUS ION
In our study, we showed that AKI was common in preterm babies and lower GA, lower Apgar scores at 5 minutes, lower systolic blood pressure, and inotropic supports were associated with the development of AKI. In addition, we found that KDIGO staging, lower diastolic blood pressures, oliguria, preeclampsia/eclampsia, large PDA, inotropic support, and furosemide treatment were associated with higher mortality in these babies. Prenatal factors and medical devices were also associated with AKI. It is very important to identify all preterm babies who are at high risk of developing AKI as quickly as possible. Early interventions should be considered in the management of LBW babies at risk for the development of AKI. We should remember that early detection of risk factors can reduce the mortality of AKI patients. 
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